4.6 Article

Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease

Journal

THROMBOSIS AND HAEMOSTASIS
Volume 106, Issue 5, Pages 885-892

Publisher

GEORG THIEME VERLAG KG
DOI: 10.1160/TH11-03-0180

Keywords

Bleeding; menorrhagia; postpartum haemorrhage; von Willebrand disease; hysterectomy

Funding

  1. Dutch Hemophilia Foundation
  2. CSL Behring
  3. Bayer Schering Pharma
  4. Baxter
  5. ZLB Behring
  6. Novo Nordisk
  7. Wyeth

Ask authors/readers for more resources

A nation-wide cross-sectional study was initiated to assess gynaecological and obstetrical symptoms in an unselected cohort of women with moderate and severe von Willebrand disease (VWD) in the Netherlands. A total of 423 women aged >= 16 years were included. Bleeding severity was measured using the Tosetto Bleeding Score (BS). Menorrhagia, defined as occurrence of >= 2 menorrhagia symptoms, was reported by 81%. Of all VWD women, 78% received any kind of treatment for menorrhagia and 20% underwent a hysterectomy predominantly because of severe menstrual bleeding. Over half of the women reported more blood loss than can be expected with a normal delivery. In 52% of reported pregnancy losses curettage was needed because of bleeding. Mean number of live births was 1.9, which is comparable with the general Dutch population. In conclusion, women with moderate or severe VWD frequently have menorrhagia in need of treatment, and 20% of the VWD women underwent a hysterectomy. Bleeding complications occurred in over 50% of the women after childbirth or pregnancy loss. Progeny seems not to be affected in women with moderate or severe VWD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available